½ÃÀ庸°í¼­
»óǰÄÚµå
1741433

±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå : ±¸¼º ¿ä¼Òº°, ±â¼úº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°

Climate Resilient and Sustainable Health Systems Market, By Component, By Technology, By End-User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2025³â¿¡´Â 107¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2032³â¿¡´Â 245¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³âÀÇ ¿¬°£ Æò±Õ ¼ºÀå·ü(CAGR)Àº 12.6%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2024³â ½ÃÀå ±Ô¸ð(2025³â) 107¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø±â°£(2025-2032³â) CAGR 12.60% °¡Ä¡ ¿¹Ãø(2032³â) 245¾ï 8,000¸¸ ´Þ·¯

±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛÀº ±âÈÄ º¯È­·Î ÀÎÇÑ °úÁ¦¿¡ ´ëóÇÏ°í ¼¼°è Áö¿ª»çȸÀÇ ÇູÀ» È®º¸Çϱâ À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

º» º¸°í¼­´Â ¼¼°èÀÇ ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù.

±×·¯³ª ½ÃÀåÀ» ¾ïÁ¦ÇÏ´Â °úÁ¦µµ ÀÖ½À´Ï´Ù.Àç¿ø°ú ÀÎÇÁ¶ó°¡ ÇÑÁ¤µÇ¾î Àֱ⠶§¹®¿¡ ƯÈ÷ °³¹ß µµ»ó Áö¿ªÀÇ Çコ ÄÉ¾î ½Ã½ºÅÛ¿¡ À־, ±âÈÄ º¯µ¿¿¡ °­ÇÏ°Ô Áö¼Ó °¡´ÉÇÑ ¼Ö·ç¼ÇÀÇ µµÀÔÀÌ ¹æÇصǰí ÀÖ½À´Ï´Ù.

±×·³¿¡µµ ºÒ±¸Çϰí ÀÌ ½ÃÀå¿¡´Â ÃæºÐÇÑ ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¿ë Àý°¨À¸·Î À̾îÁý´Ï´Ù. ¿ø°Ý ÀÇ·á ¹× µðÁöÅÐ °Ç°­ ¼Ö·ç¼ÇÀÇ Çõ½ÅÀº ¹°¸®Àû ÀÎÇÁ¶óÀÇ Çʿ伺À» ÁÙÀÓÀ¸·Î½á ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛÀÇ ±âȸ¸¦ âÃâÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • 2024³âÀ» ±âÁØ¿¬µµ·Î ÇÑ ¿¹Ãø ±â°£¿¡ À־ ¼¼°è ½ÃÀå ±Ô¸ð¡¤CAGRÀÇ »ó¼¼ ºÐ¼®.
  • ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¿Í ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½ºÀÇ ÇØ¸í.
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ ¹ß¸Å ¶Ç´Â ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·«¿¡ °üÇÑ ÁÖ¿ä ÀλçÀÌÆ®.
  • ¼¼°èÀÇ ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå¿¡ À־ÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ, ±â¾÷ Æ÷Æ®Æú¸®¿À, À繫 ½ÇÀû, ÁÖ¿äÇÑ ÇÏÀ̶óÀÌÆ®, Àü·«À» °ÔÀç.
  • Johnson Controls, Honeywell, Schneider Electric, Siemens Healthineers, Philips, GSK, AbbVie, Pfizer, Merck & Co. Novartis µî ÁÖ¿ä ±â¾÷À» ¸Á¶ó.
  • ¸¶ÄÉÆÃ ´ã´çÀÚ³ª °æ¿µÁøÀ» ÇâÇÑ ÇâÈÄ Á¦Ç° ¹ß¸Å, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼úÀÇ ÀÇ»ç °áÁ¤¿¡ µµ¿òÀÌ µÇ´Â ÀλçÀÌÆ®.
  • ÅõÀÚÀÚ, °ø±ÞÀÚ, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ °ü°èÀÚ¿¡ ´ëÇÑ ´ëÀÀ.
  • ¼¼°èÀÇ ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÌÇØ°ü°èÀÚÀÇ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
  • ÀÌ»ó ±â»óÀÇ ºóµµ¿Í ½É°¢µµ Áõ°¡
  • ÀçÇØ ´ëºñ¿Í »ç¾÷ ¿¬¼Ó¼ºÀÇ Á߿伺 Áõ°¡
  • Á¤Ã¥Á¶Ä¡¿Í Á¤ºÎÀÇ Áö¿ø
  • ¿Â½Ç°¡½º ¹èÃâ·® Àú°¨¿¡ ÁßÁ¡
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¿¹»êÀÇ Á¦¾à
  • ±â¼úÀû º¹À⼺
    • ±âȸ
  • ±âÈÄ¿¡ ¹è·ÁÇÑ ¿î¿ëÀ» À§ÇÑ µ¥ÀÌÅÍ ºÐ¼®°ú AI
  • ±âÈÄÀ§Çè Æò°¡ ¹× ¿¹Ãø Ç÷§Æû
  • Áö¼Ó°¡´ÉÇÑ ÀÇ·á±â¼ú
  • ¿µÇ⠺м®
  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Ç° Ãâ½Ã/½ÂÀÎ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • ÇÕº´°ú Àμö ½Ã³ª¸®¿À

Á¦4Àå ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå : COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • COVID-19 ¿ªÇÐ
  • °ø±ÞÃø°ú ¼ö¿äÃøÀÇ ºÐ¼®
  • °æÁ¦¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå : ±¸¼º ¿ä¼Òº°(2020-2032³â)

  • Á¦Ç°
  • ¼­ºñ½º
  • ±¸Çö ¼­ºñ½º
  • Æ®·¹ÀÌ´× ¼­ºñ½º
  • Áö¿ø ¹× À¯Áöº¸¼ö ¼­ºñ½º
  • ÄÁ¼³ÆÃ ¼­ºñ½º
  • ÅëÇÕ ¼­ºñ½º

Á¦6Àå ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå : ±â¼úº°(2020-2032³â)

  • Àü±âÈ­ÇÐ ¼¾¼­
  • ºñºÐ»ê Àû¿Ü¼±(NDIR) ¼¾¼­
  • ±Ý¼Ó »êÈ­¹° ¹ÝµµÃ¼(MOS) ¼¾¼­

Á¦7Àå ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2032³â)

  • Á¦¾àȸ»ç
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • º´¿ø

Á¦8Àå ±âÈÄ Åº·ÂÀû ¹× Áö¼Ó °¡´É º¸°Ç ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°(2020-2032³â)

  • ºÏ¹Ì
      • ¹Ì±¹
      • ij³ª´Ù
  • À¯·´
      • ¿µ±¹
      • µ¶ÀÏ
      • ÇÁ¶û½º
      • ÀÌÅ»¸®¾Æ
      • ½ºÆäÀÎ
      • ·¯½Ã¾Æ
      • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
      • Áß±¹
      • ÀϺ»
      • Àεµ
      • È£ÁÖ
      • Çѱ¹
      • ASEAN
      • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿
      • GCC ±¹°¡
      • À̽º¶ó¿¤
      • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • Johnson Controls
  • Honeywell
  • Schneider Electric
  • Siemens Healthineers
  • Philips
  • GSK
  • AbbVie
  • Pfizer
  • Merck & Co.
  • Novartis

Á¦10Àå ¼½¼Ç

  • Á¶»ç ¹æ¹ý
  • ÃâÆÇ»ç¿¡ ´ëÇØ
KTH 25.06.20

Climate Resilient and Sustainable Health Systems Market is estimated to be valued at USD 10.71 Bn in 2025 and is expected to reach USD 24.58 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 10.71 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.60% 2032 Value Projection: USD 24.58 Bn

Climate Resilient and Sustainable Health Systems are crucial for addressing the challenges that arise from climate change and ensuring the well-being of communities worldwide. With the increasing impact of climate change on human health, the need for resilient and sustainable healthcare systems has become more pressing than ever.

This report aims to provide an in-depth analysis of the global Climate Resilient and Sustainable Health Systems market. It examines the market size, estimated to reach US$ Million, and the compound annual growth rate for the forecast period of 2025-2032, with 2024 as the base year. The report delves into potential revenue opportunities across different segments and explains attractive investment propositions for this market.

Market Dynamics:

The Climate Resilient and Sustainable Health Systems market is driven by several factors. Firstly, the growing awareness of the impacts of climate change on health is pushing governments and healthcare organizations to prioritize climate resilience and sustainability. This is leading to increased investments in technologies and practices that reduce healthcare's carbon footprint and enhance the adaptive capacity of health systems.

However, there are also challenges restraining the market. Limited financial resources and infrastructure hinder the implementation of climate resilient and sustainable solutions in healthcare systems, particularly in developing regions. Additionally, the lack of standardized frameworks and guidelines for assessing and addressing climate risks in healthcare poses a barrier.

Nevertheless, there are ample opportunities in this market. The integration of renewable energy sources, such as solar power and geothermal energy, into healthcare facilities not only reduces carbon emissions but also offers cost savings in the long run. Innovations in telehealth and digital health solutions are also creating opportunities for climate resilient and sustainable healthcare systems by reducing the need for physical infrastructure.

Key Features of the Study:

  • In-depth analysis of the global market size and compound annual growth rate for the forecast period, with 2024 as the base year.
  • Elucidation of potential revenue opportunities across different segments and attractive investment proposition matrices for the market.
  • Key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Profiles of key players in the global Climate Resilient and Sustainable Health Systems market, highlighting their company portfolio, financial performance, key highlights, and strategies.
  • Coverage of key companies such as Johnson Controls, Honeywell, Schneider Electric, Siemens Healthineers, Philips, GSK, AbbVie, Pfizer, Merck & Co., and Novartis.
  • Insights to aid decision-making for future product launches, market expansion, and marketing tactics by marketers and management authorities.
  • Catering to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Ease in decision-making for stakeholders through various strategy matrices used in analyzing the global Climate Resilient and Sustainable Health Systems market.

Climate Resilient and Sustainable Health Systems Market Segmentation

  • By Component
    • Solutions
    • Energy Efficiency Systems
    • Renewable Energy Systems
    • Water Conservation Systems
    • Resilient IT Infrastructure
    • Others
    • Services
    • Implementation Services
    • Training Services
    • Support & Maintenance Services
    • Consulting Services
    • Integration Services
  • By End User
    • Healthcare Providers
    • Hospitals
    • Ambulatory Care Centers
    • Diagnostic Centers
    • Others
    • Healthcare Payers
    • Private Payers
    • Public Payers
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles
    • Johnson Controls
    • Honeywell
    • Schneider Electric
    • Siemens Healthineers
    • Philips
    • GSK
    • AbbVie
    • Pfizer
    • Merck & Co.
    • Novartis

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Climate Resilient and Sustainable Health Systems, By Component
    • Market Climate Resilient and Sustainable Health Systems, By Technology
    • Market Climate Resilient and Sustainable Health Systems, By End User
    • Market Climate Resilient and Sustainable Health Systems, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing frequency and severity of extreme weather events
  • Rising emphasis on disaster preparedness and business continuity
  • Policy measures and government support
  • Focus on reducing greenhouse gas emissions
    • Restraints
  • Budget constraints
  • Technical complexity
    • Opportunities
  • Data analytics and AI for climate-smart operations
  • Climate risk assessment and forecasting platforms
  • Sustainable medical technology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Climate Resilient and Sustainable Health Systems Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Climate Resilient and Sustainable Health Systems Market , By Component, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Product
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Implementation Services
  • Training Services
  • Support & Maintenance Services
  • Consulting Services
  • Integration Services

6. Climate Resilient and Sustainable Health Systems Market , By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Electrochemical sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Non-Dispersive Infrared (NDIR) Sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Metal Oxide Semiconductor (MOS) Sensors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Climate Resilient and Sustainable Health Systems Market , By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis,
    • Segment Trends
  • Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Climate Resilient and Sustainable Health Systems Market , By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Region/, 2020-2032,(US$ Bn)
  • South Africa
  • Central Africa
  • North Africa

9. Competitive Landscape

  • Johnson Controls
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Honeywell
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Schneider Electric
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Philips
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GSK
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AbbVie
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Pfizer
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Merck & Co.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦